{"ticker": {"uuid": "62d37a00-90c8-41d9-83ff-8af28e27358a", "symbol": "JNJB34", "name": "Johnson & Johnson", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Johnson & Johnson (JNJ)\u2019s $5.5B Talc Settlement: Turning Point or Temporary Relief?", "summary": "The World Health Organization projects that the share of the world's population aged 60 years and older will almost double from 12% in 2015 to 22% by 2050. The Population Reference Bureau expects the number of Americans aged 65 and older to climb from 58 million in 2022 to 82 million by 2050. The aging population is fueling demand for healthcare. US healthcare spending is forecast to hit $6 trillion in 2026 from $5.7 trillion in 2025. This trend reflects an expanding market for medical products companies. Yet for large healthcare companies, legal issues can erode the benefits of favorable mark", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-5-5b-230726728.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-5-5b-230726728.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-13T23:07:26+00:00", "published_display": "13 Aug 2026 23:07", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.036103, "evidence_share": 11.2, "evidence_share_display": "11.2", "freshness_pct": 94.9, "age_days": 0.1, "influence_label": "Medium", "duplicate_count": 1, "topics": ["Diversification", "Healthcare", "Hedge Funds", "Pharmaceuticals", "Talc Settlement"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson (JNJ) Advances Seltorexant And Expands Outpatient Cardiac Care", "summary": "Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Johnson & Johnson (NYSE: JNJ) is advancing its novel antidepressant Seltorexant into late stage clinical development for major depressive disorder as a potential rapid acting treatment option. The company also entered a multi year partnership with ACCESS to expand adoption of advanced cardiac electrophysiology technologies in ambulatory surgery centers. Both moves align with Johnson & Johnson's focus on higher growth therapeutic and medtech areas that are important for its lo", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-advances-seltorexant-161141375.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-advances-seltorexant-161141375.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-12T16:11:41+00:00", "published_display": "12 Aug 2026 16:11", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.034536, "evidence_share": 10.8, "evidence_share_display": "10.8", "freshness_pct": 60.7, "age_days": 1.4, "influence_label": "Medium", "duplicate_count": 1, "topics": ["CARDIOVASCULAR", "CLINICAL-TRIALS", "Cardiovascular", "Clinical Trials", "MEDTECH", "Medtech"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Johnson+%26+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference%22+%22Business+Wire%22", "source_link_is_lookup": true, "source_name": "Business Wire", "published_at": "2026-08-10T20:27:00+00:00", "published_display": "10 Aug 2026 20:27", "source_kind": "press_release", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.019575, "evidence_share": 6.1, "evidence_share_display": "6.1", "freshness_pct": 32.3, "age_days": 3.3, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava\u2019s FDA Approval?", "summary": "Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J's MedTech ambitions, but the company is entering a market in which Intuitive Surgical (NASDAQ:ISRG) already has an extensive installed base, established surgeon relationships, and a rapidly expanding da Vinci 5 platform. The question for investors is not whether OTTAVA can become a viable product, but whether Johnson & Johnson (NYSE:JNJ) can convert its differ", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-challenge-intuitive-124242559.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-challenge-intuitive-124242559.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-10T12:42:42+00:00", "published_display": "10 Aug 2026 12:42", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035182, "evidence_share": 11.0, "evidence_share_display": "11", "freshness_pct": 60.8, "age_days": 3.6, "influence_label": "Medium", "duplicate_count": 1, "topics": ["FDA-APPROVAL", "FINANCIAL RESULTS", "Fda Approval", "Financial Results", "HEALTHCARE", "Healthcare"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.", "summary": "Key Points Few companies have a longer track record of uninterrupted dividend growth. This streak is likely to be prolonged well into the foreseeable future. While still an income stock, Johnson & Johnson is also being priced somewhat like a growth stock.10 stocks we like better than Johnson & Johnson \u203a It's certainly not the market's most exciting stock, and not its highest-yielding one either. If you want reliable dividend growth, though, you'd be hard-pressed to find a better option than drugmaker Johnson & Johnson(NYSE: JNJ). In fact, after 64 straight years of annual dividend increases --", "url": "https://www.nasdaq.com/articles/johnson-johnson-has-increased-its-dividend-64-consecutive-years-heres-how-much-10000", "source_link": "https://www.nasdaq.com/articles/johnson-johnson-has-increased-its-dividend-64-consecutive-years-heres-how-much-10000", "source_link_is_lookup": false, "source_name": "nasdaq.com", "published_at": "2026-08-09T13:35:00+00:00", "published_display": "09 Aug 2026 13:35", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 71, "tone_signals": ["Capital returned"], "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.12276, "evidence_share": 38.2, "evidence_share_display": "38.2", "freshness_pct": 63.7, "age_days": 4.5, "influence_label": "High", "duplicate_count": 1, "topics": ["Acquisitions", "Dividends", "Markets", "Oncology", "Pharmaceuticals"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Johnson+%26+Johnson+vs.+Eli+Lilly%3A+Reliable+Stability+vs.+Rapid+Revenue+Growth%22+%22AOL.com%22", "source_link_is_lookup": true, "source_name": "AOL.com", "published_at": "2026-08-07T23:29:01.870412+00:00", "published_display": "07 Aug 2026 23:29", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 66, "tone_signals": ["Operating growth"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.013065, "evidence_share": 4.1, "evidence_share_display": "4.1", "freshness_pct": 11.9, "age_days": 6.1, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits", "summary": "Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Johnson & Johnson (NYSE: JNJ) agreed to a US$5.5b settlement to resolve tens of thousands of talc baby powder lawsuits. The deal ends decades of litigation over alleged health risks tied to the company's talc-based products. The settlement follows years of high profile trials and failed bankruptcy attempts related to the talc claims. This resolution removes a long running legal overhang and brings more clarity for Johnson & Johnson investors. Consider broadening your research to o", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-reaches-5-191035095.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-reaches-5-191035095.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-07T19:10:35+00:00", "published_display": "07 Aug 2026 19:10", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035582, "evidence_share": 11.1, "evidence_share_display": "11.1", "freshness_pct": 53.5, "age_days": 6.3, "influence_label": "Medium", "duplicate_count": 1, "topics": ["BALANCE SHEET", "Balance Sheet", "CONSUMER-HEALTH", "Consumer Health", "LEGAL-ISSUES", "Legal Issues"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson announces quarterly dividend of US$ 0.09 per BDR for JNJB34 program", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Johnson+%26+Johnson+announces+quarterly+dividend+of+US%24+0.09+per+BDR+for+JNJB34+program%22+%22Bitget%22", "source_link_is_lookup": true, "source_name": "Bitget", "published_at": "2026-08-03T06:19:00.926720+00:00", "published_display": "03 Aug 2026 06:19", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.017368, "evidence_share": 5.4, "evidence_share_display": "5.4", "freshness_pct": 22.2, "age_days": 10.8, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Johnson & Johnson stock trades steadily as diversified healthcare earnings support valuation", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Johnson+%26+Johnson+stock+trades+steadily+as+diversified+healthcare+earnings+support+valuation%22+%22Ad-hoc-news.de%22", "source_link_is_lookup": true, "source_name": "Ad-hoc-news.de", "published_at": "2026-07-27T06:18:43.710069+00:00", "published_display": "27 Jul 2026 06:18", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006927, "evidence_share": 2.2, "evidence_share_display": "2.2", "freshness_pct": 8.4, "age_days": 17.9, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Why+Johnson+%26+Johnson+Is+Sending+Intuitive+Surgical+%28ISRG%29+Stock+Down+Today%22+%22Barchart.com%22", "source_link_is_lookup": true, "source_name": "Barchart.com", "published_at": "2026-07-23T07:41:39.520250+00:00", "published_display": "23 Jul 2026 07:41", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2.8e-05, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.1, "age_days": 21.8, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Unusual Put Option Activity in Johnson & Johnson After JNJ Stock's Recent Runup", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Unusual+Put+Option+Activity+in+Johnson+%26+Johnson+After+JNJ+Stock%27s+Recent+Runup%22+%22Barchart.com%22", "source_link_is_lookup": true, "source_name": "Barchart.com", "published_at": "2026-07-21T11:48:43.439059+00:00", "published_display": "21 Jul 2026 11:48", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 1.5e-05, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.0, "age_days": 23.6, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}], "by_tier": {"direct": [{"title": "Johnson & Johnson (JNJ)\u2019s $5.5B Talc Settlement: Turning Point or Temporary Relief?", "summary": "The World Health Organization projects that the share of the world's population aged 60 years and older will almost double from 12% in 2015 to 22% by 2050. The Population Reference Bureau expects the number of Americans aged 65 and older to climb from 58 million in 2022 to 82 million by 2050. The aging population is fueling demand for healthcare. US healthcare spending is forecast to hit $6 trillion in 2026 from $5.7 trillion in 2025. This trend reflects an expanding market for medical products companies. Yet for large healthcare companies, legal issues can erode the benefits of favorable mark", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-5-5b-230726728.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-5-5b-230726728.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-13T23:07:26+00:00", "published_display": "13 Aug 2026 23:07", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "JNJ.US", "provider_symbols": ["ABBV.US", "JNJ.US"], "target_provider_symbol": "JNJ.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "c3a98a5f8747a521982b0d128ec0396d98d710f52be0af746179603a914f830a", "target_scope": "Johnson & Johnson (JNJ)\u2019s $5.5B Talc Settlement: Turning Point or Temporary Relief?", "durable_archive": false, "archive_provider": "", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": 0.2452, "relevance_score": 0.795492, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.036103, "evidence_share": 11.2, "evidence_share_display": "11.2", "freshness_pct": 94.9, "age_days": 0.1, "influence_label": "Medium", "duplicate_count": 1, "topics": ["Diversification", "Healthcare", "Hedge Funds", "Pharmaceuticals", "Talc Settlement"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson (JNJ) Advances Seltorexant And Expands Outpatient Cardiac Care", "summary": "Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Johnson & Johnson (NYSE: JNJ) is advancing its novel antidepressant Seltorexant into late stage clinical development for major depressive disorder as a potential rapid acting treatment option. The company also entered a multi year partnership with ACCESS to expand adoption of advanced cardiac electrophysiology technologies in ambulatory surgery centers. Both moves align with Johnson & Johnson's focus on higher growth therapeutic and medtech areas that are important for its lo", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-advances-seltorexant-161141375.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-advances-seltorexant-161141375.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-12T16:11:41+00:00", "published_display": "12 Aug 2026 16:11", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "JNJ.US", "provider_symbols": ["JNJ.US", "JNJB34.ARCHIVE"], "target_provider_symbol": "JNJ.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "9073c5771f91b89c5e6ebe007a507f5ff605ec1bb6a0376e88f53fbdfcbb6eb0", "target_scope": "Johnson & Johnson (JNJ) Advances Seltorexant And Expands Outpatient Cardiac Care Johnson & Johnson (NYSE: JNJ) is advancing its novel antidepressant Seltorexant into late stage clinical development for major depressive disorder as a potential rapid acting treatment option. Both moves align with Johnson & Johnson's focus on higher growth therapeutic and medtech areas that are important for its lo", "durable_archive": false, "archive_provider": "", "sentiment_origin": "stored_reclassified", "model_confidence": 0.461, "provider_directional_mass": 0.125, "relevance_score": 0.9, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.034536, "evidence_share": 10.8, "evidence_share_display": "10.8", "freshness_pct": 60.7, "age_days": 1.4, "influence_label": "Medium", "duplicate_count": 1, "topics": ["CARDIOVASCULAR", "CLINICAL-TRIALS", "Cardiovascular", "Clinical Trials", "MEDTECH", "Medtech"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Johnson+%26+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference%22+%22Business+Wire%22", "source_link_is_lookup": true, "source_name": "Business Wire", "published_at": "2026-08-10T20:27:00+00:00", "published_display": "10 Aug 2026 20:27", "provider": "archive", "providers": ["archive"], "provider_symbol": "", "provider_symbols": ["JNJB34.ARCHIVE"], "target_provider_symbol": "JNJB34.ARCHIVE", "cross_listing": false, "source_names": ["Business Wire"], "source_kind": "press_release", "story_key": "8041b7724f815501fa22226384fb5c8e710485d244be726ceb3ee92f8d52b09b", "target_scope": "Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.019575, "evidence_share": 6.1, "evidence_share_display": "6.1", "freshness_pct": 32.3, "age_days": 3.3, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava\u2019s FDA Approval?", "summary": "Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J's MedTech ambitions, but the company is entering a market in which Intuitive Surgical (NASDAQ:ISRG) already has an extensive installed base, established surgeon relationships, and a rapidly expanding da Vinci 5 platform. The question for investors is not whether OTTAVA can become a viable product, but whether Johnson & Johnson (NYSE:JNJ) can convert its differ", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-challenge-intuitive-124242559.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-challenge-intuitive-124242559.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-10T12:42:42+00:00", "published_display": "10 Aug 2026 12:42", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "JNJ.MX", "provider_symbols": ["ISRG.US", "JNJ.BA", "JNJ.DU", "JNJ.F", "JNJ.HM", "JNJ.MU", "JNJ.MX", "JNJ.US", "JNJB34.ARCHIVE", "JNJB34.SA", "MBOT.US"], "target_provider_symbol": "JNJ.MX", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "1f3a1d2d0e41f5a6089112952037dac0c453a7c78b4d75fbfa04ceabaf7c7c68", "target_scope": "Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava\u2019s FDA Approval? Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. The question for investors is not whether OTTAVA can become a viable product, but whether Johnson & Johnson (NYSE:JNJ) can convert its differ", "durable_archive": false, "archive_provider": "", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": 0.157, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035182, "evidence_share": 11.0, "evidence_share_display": "11", "freshness_pct": 60.8, "age_days": 3.6, "influence_label": "Medium", "duplicate_count": 1, "topics": ["FDA-APPROVAL", "FINANCIAL RESULTS", "Fda Approval", "Financial Results", "HEALTHCARE", "Healthcare"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.", "summary": "Key Points Few companies have a longer track record of uninterrupted dividend growth. This streak is likely to be prolonged well into the foreseeable future. While still an income stock, Johnson & Johnson is also being priced somewhat like a growth stock.10 stocks we like better than Johnson & Johnson \u203a It's certainly not the market's most exciting stock, and not its highest-yielding one either. If you want reliable dividend growth, though, you'd be hard-pressed to find a better option than drugmaker Johnson & Johnson(NYSE: JNJ). In fact, after 64 straight years of annual dividend increases --", "url": "https://www.nasdaq.com/articles/johnson-johnson-has-increased-its-dividend-64-consecutive-years-heres-how-much-10000", "source_link": "https://www.nasdaq.com/articles/johnson-johnson-has-increased-its-dividend-64-consecutive-years-heres-how-much-10000", "source_link_is_lookup": false, "source_name": "nasdaq.com", "published_at": "2026-08-09T13:35:00+00:00", "published_display": "09 Aug 2026 13:35", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "JNJ.US", "provider_symbols": ["JNJ.US"], "target_provider_symbol": "JNJ.US", "cross_listing": false, "source_names": ["nasdaq.com"], "source_kind": "publisher", "story_key": "87a1fc6b527bdca11053464b79d729c447de8f314f33673826d4f20bc8906505", "target_scope": "Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. While still an income stock, Johnson & Johnson is also being priced somewhat like a growth stock.10 stocks we like better than Johnson & Johnson \u203a It's certainly not the market's most exciting stock, and not its highest-yielding one either. If you want reliable dividend growth, though, you'd be hard-pressed to find a better option than drugmaker Johnson & Johnson(NYSE: JNJ).", "durable_archive": false, "archive_provider": "", "sentiment_origin": "stored_reclassified", "model_confidence": 0.589, "provider_directional_mass": 0.14, "relevance_score": 0.9, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 71, "tone_signals": ["Capital returned"], "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.12276, "evidence_share": 38.2, "evidence_share_display": "38.2", "freshness_pct": 63.7, "age_days": 4.5, "influence_label": "High", "duplicate_count": 1, "topics": ["Acquisitions", "Dividends", "Markets", "Oncology", "Pharmaceuticals"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Johnson+%26+Johnson+vs.+Eli+Lilly%3A+Reliable+Stability+vs.+Rapid+Revenue+Growth%22+%22AOL.com%22", "source_link_is_lookup": true, "source_name": "AOL.com", "published_at": "2026-08-07T23:29:01.870412+00:00", "published_display": "07 Aug 2026 23:29", "provider": "archive", "providers": ["archive"], "provider_symbol": "", "provider_symbols": ["JNJB34.ARCHIVE"], "target_provider_symbol": "JNJB34.ARCHIVE", "cross_listing": false, "source_names": ["AOL.com"], "source_kind": "publisher", "story_key": "5caf417867f13c7864528d742a3a46f5a163b83703fcfb41475d0aa410e7f45a", "target_scope": "Johnson & Johnson vs.", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.559, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 66, "tone_signals": ["Operating growth"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.013065, "evidence_share": 4.1, "evidence_share_display": "4.1", "freshness_pct": 11.9, "age_days": 6.1, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits", "summary": "Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Johnson & Johnson (NYSE: JNJ) agreed to a US$5.5b settlement to resolve tens of thousands of talc baby powder lawsuits. The deal ends decades of litigation over alleged health risks tied to the company's talc-based products. The settlement follows years of high profile trials and failed bankruptcy attempts related to the talc claims. This resolution removes a long running legal overhang and brings more clarity for Johnson & Johnson investors. Consider broadening your research to o", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-reaches-5-191035095.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-reaches-5-191035095.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-07T19:10:35+00:00", "published_display": "07 Aug 2026 19:10", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "JNJ.US", "provider_symbols": ["JNJ.BA", "JNJ.DU", "JNJ.F", "JNJ.HM", "JNJ.MU", "JNJ.MX", "JNJ.US", "JNJB34.ARCHIVE", "JNJB34.SA"], "target_provider_symbol": "JNJ.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "cf4c1cfdc2afd2eff01baf4bd41376d7649feff3cae6f90af7b97c54f9e6fd47", "target_scope": "Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits Johnson & Johnson (NYSE: JNJ) agreed to a US$5.5b settlement to resolve tens of thousands of talc baby powder lawsuits. This resolution removes a long running legal overhang and brings more clarity for Johnson & Johnson investors.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": 0.1371, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035582, "evidence_share": 11.1, "evidence_share_display": "11.1", "freshness_pct": 53.5, "age_days": 6.3, "influence_label": "Medium", "duplicate_count": 1, "topics": ["BALANCE SHEET", "Balance Sheet", "CONSUMER-HEALTH", "Consumer Health", "LEGAL-ISSUES", "Legal Issues"], "evidence_basis": "archived_article", "score_included": true}, {"title": "Johnson & Johnson announces quarterly dividend of US$ 0.09 per BDR for JNJB34 program", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Johnson+%26+Johnson+announces+quarterly+dividend+of+US%24+0.09+per+BDR+for+JNJB34+program%22+%22Bitget%22", "source_link_is_lookup": true, "source_name": "Bitget", "published_at": "2026-08-03T06:19:00.926720+00:00", "published_display": "03 Aug 2026 06:19", "provider": "archive", "providers": ["archive"], "provider_symbol": "", "provider_symbols": ["JNJB34.ARCHIVE"], "target_provider_symbol": "JNJB34.ARCHIVE", "cross_listing": false, "source_names": ["Bitget"], "source_kind": "publisher", "story_key": "5338c6097fe3c9e917b583c4357797d5e98ae85499e3959d9fc049eabe9b7690", "target_scope": "Johnson & Johnson announces quarterly dividend of US$ 0.09 per BDR for JNJB34 program", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.017368, "evidence_share": 5.4, "evidence_share_display": "5.4", "freshness_pct": 22.2, "age_days": 10.8, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Johnson & Johnson stock trades steadily as diversified healthcare earnings support valuation", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Johnson+%26+Johnson+stock+trades+steadily+as+diversified+healthcare+earnings+support+valuation%22+%22Ad-hoc-news.de%22", "source_link_is_lookup": true, "source_name": "Ad-hoc-news.de", "published_at": "2026-07-27T06:18:43.710069+00:00", "published_display": "27 Jul 2026 06:18", "provider": "archive", "providers": ["archive"], "provider_symbol": "", "provider_symbols": ["JNJB34.ARCHIVE"], "target_provider_symbol": "JNJB34.ARCHIVE", "cross_listing": false, "source_names": ["Ad-hoc-news.de"], "source_kind": "publisher", "story_key": "ee26d912f4bc7e6a8cbe351f7fe72f8e11eacdb4e97a4571679b93d7cc1d38c5", "target_scope": "Johnson & Johnson stock trades steadily as diversified healthcare earnings support valuation", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006927, "evidence_share": 2.2, "evidence_share_display": "2.2", "freshness_pct": 8.4, "age_days": 17.9, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Why+Johnson+%26+Johnson+Is+Sending+Intuitive+Surgical+%28ISRG%29+Stock+Down+Today%22+%22Barchart.com%22", "source_link_is_lookup": true, "source_name": "Barchart.com", "published_at": "2026-07-23T07:41:39.520250+00:00", "published_display": "23 Jul 2026 07:41", "provider": "archive", "providers": ["archive"], "provider_symbol": "", "provider_symbols": ["JNJB34.ARCHIVE"], "target_provider_symbol": "JNJB34.ARCHIVE", "cross_listing": false, "source_names": ["Barchart.com"], "source_kind": "publisher", "story_key": "8fceedd8d11632d5486ae0dbcc2ed3bb5a9bd074341a5616a0f678a5cb28da06", "target_scope": "Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2.8e-05, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.1, "age_days": 21.8, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Unusual Put Option Activity in Johnson & Johnson After JNJ Stock's Recent Runup", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Unusual+Put+Option+Activity+in+Johnson+%26+Johnson+After+JNJ+Stock%27s+Recent+Runup%22+%22Barchart.com%22", "source_link_is_lookup": true, "source_name": "Barchart.com", "published_at": "2026-07-21T11:48:43.439059+00:00", "published_display": "21 Jul 2026 11:48", "provider": "archive", "providers": ["archive"], "provider_symbol": "", "provider_symbols": ["JNJB34.ARCHIVE"], "target_provider_symbol": "JNJB34.ARCHIVE", "cross_listing": false, "source_names": ["Barchart.com"], "source_kind": "publisher", "story_key": "f44f445a715601efdd6aa44372c756d77a10296e982da167156d7bf3bfd758e3", "target_scope": "Unusual Put Option Activity in Johnson & Johnson After JNJ Stock's Recent Runup", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 1.5e-05, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.0, "age_days": 23.6, "influence_label": "Low", "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true}], "industry": [], "sector": []}, "total_fetched": 11, "total_unique": 11, "total_relevant": 11, "pipeline_health": {"eodhd": {"status": "healthy", "calls_used": 25, "configured": true, "last_error": "", "rate_limit": 1200, "call_budget": 10000, "requests_made": 5, "newest_seen_at": "2026-08-14T00:01:00+00:00", "rate_remaining": 1198, "budget_used_pct": 0.2, "last_success_at": "2026-08-14T00:17:05.539434+00:00", "mapped_mentions": 3877, "unmapped_mentions": 1813}, "status": "healthy", "raw_articles": 68, "eodhd_articles": 41, "unique_stories": 49, "direct_evidence": 11, "provider_counts": {"eodhd": 44}, "provider_errors": {}, "archive_articles": 8, "current_evidence": 11, "relevant_stories": 11, "duplicates_removed": 19, "durable_story_count": 11, "providers_attempted": 1, "durable_collected_at": "2026-08-14T00:17:24.478724+00:00", "durable_evidence_used": true, "providers_with_results": 1, "matched_archive_stories": 11, "provider_rejected_counts": {"eodhd": 39}, "provider_relevant_counts": {"eodhd": 5}, "durable_newest_article_at": "2026-08-13T23:07:26+00:00"}, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 8, "score": 52, "raw_score": 59, "total": 11, "evidence_count": 11, "effective_articles": 4.92, "information_mass": 0.321, "direct_story_count": 11, "direct_source_count": 7, "industry_story_count": 0, "sector_story_count": 0, "story_count": 11, "source_count": 7, "source_concentration": 0.3488, "direct_share": 90, "dispersion": 10, "confidence": 28, "evidence_status": "provisional", "score_version": "evidence-v9", "window_days": 30, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-08-13T23:07:26+00:00", "label": "Early balanced news score", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 3.58, "count": 6}, {"event": "earnings", "label": "Earnings", "weight": 1.15, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.6, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.6, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0, "pipeline": {"eodhd": {"status": "healthy", "calls_used": 25, "configured": true, "last_error": "", "rate_limit": 1200, "call_budget": 10000, "requests_made": 5, "newest_seen_at": "2026-08-14T00:01:00+00:00", "rate_remaining": 1198, "budget_used_pct": 0.2, "last_success_at": "2026-08-14T00:17:05.539434+00:00", "mapped_mentions": 3877, "unmapped_mentions": 1813}, "status": "healthy", "raw_articles": 68, "eodhd_articles": 41, "unique_stories": 49, "direct_evidence": 11, "provider_counts": {"eodhd": 44}, "provider_errors": {}, "archive_articles": 8, "current_evidence": 11, "relevant_stories": 11, "duplicates_removed": 19, "durable_story_count": 11, "providers_attempted": 1, "durable_collected_at": "2026-08-14T00:17:24.478724+00:00", "durable_evidence_used": true, "providers_with_results": 1, "matched_archive_stories": 11, "provider_rejected_counts": {"eodhd": 39}, "provider_relevant_counts": {"eodhd": 5}, "durable_newest_article_at": "2026-08-13T23:07:26+00:00"}}, "market_context": {"has_market_context": true, "latest_close": 87.73, "latest_week": "2026-08-07", "one_week_move": 0.7, "four_week_move": 0.4, "twelve_week_move": 15.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.788346, "market_dynamics_buy_signal": false, "relative_strength": 11.650793, "fair_value_gap": 42.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 44.7257, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.7% over one week, +0.4% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Early company-news score", "tone": "neutral", "classification": "provisional", "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 28, "badges": ["Provisional evidence"], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 4}, {"label": "Barchart.com", "count": 2}, {"label": "Business Wire", "count": 1}, {"label": "nasdaq.com", "count": 1}, {"label": "AOL.com", "count": 1}, {"label": "Bitget", "count": 1}, {"label": "Ad-hoc-news.de", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Earnings", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Early balanced news score"}, {"label": "Evidence confidence", "value": "28/100", "tone": "neutral", "text": "4.92 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Early company-news score", "tone": "neutral", "text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 evidence concentration around this catalyst."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "90% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "10/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.7% over one week, +0.4% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Johnson & Johnson (JNJ)\u2019s $5.5B Talc Settlement: Turning Point or Temporary Relief?"}], "updated_at": "2026-08-14T00:17:24.478724+00:00", "detail_intelligence": {"headline": "Early balanced news score", "summary": "11 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 52, "display": "52", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 28, "display": "28", "tone": "negative", "note": "thin evidence"}, {"label": "Company news", "value": 90, "display": "90%", "tone": "positive", "note": "11 company stories"}, {"label": "Story agreement", "value": 90, "display": "90", "tone": "positive", "note": "10/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 6, "note": "0.321 after freshness weighting"}, {"label": "Source breadth", "value": 100, "note": "7 independent publishers"}, {"label": "Company relevance", "value": 90, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 52, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 90, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 65, "note": "less reliance on one publisher"}], "freshness": 52, "source_independence": 65, "timeline": [{"date": "2026-07-16", "label": "16 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-17", "label": "17 Jul", "count": 0, "score": null, "tone": "neutral", "x": 73.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-18", "label": "18 Jul", "count": 0, "score": null, "tone": "neutral", "x": 105.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-19", "label": "19 Jul", "count": 0, "score": null, "tone": "neutral", "x": 136.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-20", "label": "20 Jul", "count": 0, "score": null, "tone": "neutral", "x": 168.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-21", "label": "21 Jul", "count": 1, "score": 50, "tone": "neutral", "x": 199.9, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-22", "label": "22 Jul", "count": 0, "score": null, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-23", "label": "23 Jul", "count": 1, "score": 50, "tone": "neutral", "x": 263.1, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 294.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 326.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 357.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 1, "score": 50, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 452.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 484.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 515.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 547.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 579.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 610.6, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 642.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 673.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 2, "score": 54, "tone": "neutral", "x": 736.9, "y": 127.7, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 768.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 1, "score": 71, "tone": "positive", "x": 800.1, "y": 96.8, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 2, "score": 50, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 0, "score": null, "tone": "neutral", "x": 863.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 1, "score": 57, "tone": "neutral", "x": 894.8, "y": 122.3, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-14", "label": "14 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "199.9,135.0 263.1,135.0 389.4,135.0 610.6,135.0 736.9,127.7 800.1,96.8 831.7,135.0 894.8,122.3 926.4,135.0", "timeline_has_signal": true, "timeline_start": "16 Jul", "timeline_mid": "31 Jul", "timeline_end": "14 Aug", "momentum": {"label": "Tentative cooling", "tone": "neutral", "recent_score": 53, "prior_score": 65, "delta": -12, "recent_count": 2, "prior_count": 3, "volume_delta": -1, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "early_change": {"label": "New stories need a baseline", "tone": "neutral", "latest_score": 50, "baseline_score": 62, "delta": null, "latest_count": 1, "baseline_count": 6, "confirmed": false, "note": "A comparison needs current and earlier-week company news"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 1, "share": 9}, {"label": "1 to 3 days", "count": 1, "share": 9}, {"label": "4 to 7 days", "count": 5, "share": 45}, {"label": "8 to 14 days", "count": 1, "share": 9}, {"label": "15 to 21 days", "count": 1, "share": 9}, {"label": "22 to 30 days", "count": 2, "share": 18}], "source_profile": [{"label": "finance.yahoo.com", "count": 4, "share": 36, "score": 52, "tone": "neutral"}, {"label": "Barchart.com", "count": 2, "share": 18, "score": 50, "tone": "neutral"}, {"label": "nasdaq.com", "count": 1, "share": 9, "score": 71, "tone": "positive"}, {"label": "AOL.com", "count": 1, "share": 9, "score": 66, "tone": "positive"}, {"label": "Business Wire", "count": 1, "share": 9, "score": 50, "tone": "neutral"}, {"label": "Bitget", "count": 1, "share": 9, "score": 50, "tone": "neutral"}, {"label": "Ad-hoc-news.de", "count": 1, "share": 9, "score": 50, "tone": "neutral"}], "event_profile": [{"label": "Market update", "count": 6, "share": 55, "score": 54, "tone": "neutral"}, {"label": "Earnings", "count": 2, "share": 18, "score": 50, "tone": "neutral"}, {"label": "Deals and strategy", "count": 1, "share": 9, "score": 71, "tone": "positive"}, {"label": "Regulatory and legal", "count": 1, "share": 9, "score": 50, "tone": "neutral"}, {"label": "Capital return", "count": 1, "share": 9, "score": 50, "tone": "neutral"}], "topics": [{"label": "Pharmaceuticals", "count": 2, "share": 18}, {"label": "Healthcare", "count": 2, "share": 18}, {"label": "Talc Settlement", "count": 1, "share": 9}, {"label": "Oncology", "count": 1, "share": 9}, {"label": "Medtech", "count": 1, "share": 9}, {"label": "Markets", "count": 1, "share": 9}, {"label": "MEDTECH", "count": 1, "share": 9}, {"label": "Legal Issues", "count": 1, "share": 9}, {"label": "LEGAL-ISSUES", "count": 1, "share": 9}, {"label": "Hedge Funds", "count": 1, "share": 9}], "supporting": [{"label": "Direct evidence", "text": "11 current stories are mapped specifically to JNJB34."}, {"label": "Source breadth", "text": "The score uses 7 publishers rather than depending on one outlet."}], "tempering": [{"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.321."}, {"label": "Confidence", "text": "Confidence is 28/100, below the threshold for a firm score."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"title": "Johnson & Johnson (JNJ)\u2019s $5.5B Talc Settlement: Turning Point or Temporary Relief?", "summary": "The World Health Organization projects that the share of the world's population aged 60 years and older will almost double from 12% in 2015 to 22% by 2050. The Population Reference Bureau expects the number of Americans aged 65 and older to climb from 58 million in 2022 to 82 million by 2050. The aging population is fueling demand for healthcare. US healthcare spending is forecast to hit $6 trillion in 2026 from $5.7 trillion in 2025. This trend reflects an expanding market for medical products companies. Yet for large healthcare companies, legal issues can erode the benefits of favorable mark", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-5-5b-230726728.html", "source_link": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-5-5b-230726728.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-13T23:07:26+00:00", "published_display": "13 Aug 2026 23:07", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.036103, "evidence_share": 11.2, "evidence_share_display": "11.2", "freshness_pct": 94.9, "age_days": 0.1, "influence_label": "Medium", "duplicate_count": 1, "topics": ["Diversification", "Healthcare", "Hedge Funds", "Pharmaceuticals", "Talc Settlement"], "evidence_basis": "archived_article", "score_included": true}, "article_count": 11, "updated_at": "2026-08-14T00:17:24.478724+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 115.6, "label": "13 Feb 2026", "close": 83.7, "index": 100.0}, {"x": 78.4, "y": 124.4, "label": "20 Feb 2026", "close": 82.57, "index": 98.7}, {"x": 114.9, "y": 111.5, "label": "27 Feb 2026", "close": 84.24, "index": 100.6}, {"x": 151.3, "y": 119.2, "label": "06 Mar 2026", "close": 83.24, "index": 99.5}, {"x": 187.7, "y": 100.8, "label": "13 Mar 2026", "close": 85.62, "index": 102.3}, {"x": 224.2, "y": 123.6, "label": "20 Mar 2026", "close": 82.67, "index": 98.8}, {"x": 260.6, "y": 118.4, "label": "27 Mar 2026", "close": 83.34, "index": 99.6}, {"x": 297.0, "y": 118.5, "label": "03 Apr 2026", "close": 83.32, "index": 99.6}, {"x": 333.5, "y": 151.6, "label": "10 Apr 2026", "close": 79.05, "index": 94.5}, {"x": 369.9, "y": 163.0, "label": "17 Apr 2026", "close": 77.58, "index": 92.7}, {"x": 406.3, "y": 173.8, "label": "24 Apr 2026", "close": 76.18, "index": 91.0}, {"x": 442.8, "y": 179.8, "label": "01 May 2026", "close": 75.41, "index": 90.1}, {"x": 479.2, "y": 204.2, "label": "08 May 2026", "close": 72.25, "index": 86.3}, {"x": 515.6, "y": 172.8, "label": "15 May 2026", "close": 76.3, "index": 91.2}, {"x": 552.0, "y": 156.4, "label": "22 May 2026", "close": 78.42, "index": 93.7}, {"x": 588.5, "y": 178.7, "label": "29 May 2026", "close": 75.55, "index": 90.3}, {"x": 624.9, "y": 155.5, "label": "05 Jun 2026", "close": 78.54, "index": 93.8}, {"x": 661.3, "y": 134.3, "label": "12 Jun 2026", "close": 81.29, "index": 97.1}, {"x": 697.8, "y": 121.5, "label": "19 Jun 2026", "close": 82.94, "index": 99.1}, {"x": 734.2, "y": 87.8, "label": "26 Jun 2026", "close": 87.3, "index": 104.3}, {"x": 770.6, "y": 55.8, "label": "03 Jul 2026", "close": 91.43, "index": 109.2}, {"x": 807.1, "y": 87.0, "label": "10 Jul 2026", "close": 87.4, "index": 104.4}, {"x": 843.5, "y": 101.9, "label": "17 Jul 2026", "close": 85.47, "index": 102.1}, {"x": 879.9, "y": 73.2, "label": "24 Jul 2026", "close": 89.18, "index": 106.6}, {"x": 916.4, "y": 89.2, "label": "31 Jul 2026", "close": 87.11, "index": 104.1}, {"x": 952.8, "y": 84.4, "label": "07 Aug 2026", "close": 87.73, "index": 104.8}], "sentiment_points": [{"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "label": "26 Jun 2026", "score": 59, "tone": "positive", "raw_score": 76, "confidence": 37, "stories": 3, "close": 87.3, "price_change": 5.3, "x": 739.4, "y": 113.4, "show_label": true, "label_y": 103.4}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "label": "03 Jul 2026", "score": 55, "tone": "neutral", "raw_score": 74, "confidence": 27, "stories": 4, "close": 91.43, "price_change": 4.7, "x": 775.8, "y": 120.8, "show_label": true, "label_y": 110.8}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "label": "10 Jul 2026", "score": 53, "tone": "neutral", "raw_score": 74, "confidence": 21, "stories": 5, "close": 87.4, "price_change": -4.4, "x": 812.3, "y": 124.5, "show_label": true, "label_y": 114.5}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 52, "tone": "neutral", "raw_score": 76, "confidence": 18, "stories": 5, "close": 85.47, "price_change": -2.2, "x": 848.7, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 51, "tone": "neutral", "raw_score": 57, "confidence": 23, "stories": 7, "close": 89.18, "price_change": 4.3, "x": 885.1, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 52, "confidence": 22, "stories": 6, "close": 87.11, "price_change": -2.3, "x": 921.6, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 52, "tone": "neutral", "raw_score": 58, "confidence": 32, "stories": 8, "close": 87.73, "price_change": 0.7, "x": 958.0, "y": 126.3, "show_label": true, "label_y": 116.3}], "price_path": "42.0,115.6 78.4,124.4 114.9,111.5 151.3,119.2 187.7,100.8 224.2,123.6 260.6,118.4 297.0,118.5 333.5,151.6 369.9,163.0 406.3,173.8 442.8,179.8 479.2,204.2 515.6,172.8 552.0,156.4 588.5,178.7 624.9,155.5 661.3,134.3 697.8,121.5 734.2,87.8 770.6,55.8 807.1,87.0 843.5,101.9 879.9,73.2 916.4,89.2 952.8,84.4", "sentiment_path": "739.4,113.4 775.8,120.8 812.3,124.5 848.7,126.3 885.1,128.2 921.6,130.0 958.0,126.3", "score_version": "evidence-v9", "price_change": 4.8, "sentiment_change": -7, "recent_pairs": [{"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 52, "tone": "neutral", "raw_score": 58, "confidence": 32, "stories": 8, "close": 87.73, "price_change": 0.7, "x": 958.0, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 52, "confidence": 22, "stories": 6, "close": 87.11, "price_change": -2.3, "x": 921.6, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 51, "tone": "neutral", "raw_score": 57, "confidence": 23, "stories": 7, "close": 89.18, "price_change": 4.3, "x": 885.1, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 52, "tone": "neutral", "raw_score": 76, "confidence": 18, "stories": 5, "close": 85.47, "price_change": -2.2, "x": 848.7, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "label": "10 Jul 2026", "score": 53, "tone": "neutral", "raw_score": 74, "confidence": 21, "stories": 5, "close": 87.4, "price_change": -4.4, "x": 812.3, "y": 124.5, "show_label": true, "label_y": 114.5}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "label": "03 Jul 2026", "score": 55, "tone": "neutral", "raw_score": 74, "confidence": 27, "stories": 4, "close": 91.43, "price_change": 4.7, "x": 775.8, "y": 120.8, "show_label": true, "label_y": 110.8}, {"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "label": "26 Jun 2026", "score": 59, "tone": "positive", "raw_score": 76, "confidence": 37, "stories": 3, "close": 87.3, "price_change": 5.3, "x": 739.4, "y": 113.4, "show_label": true, "label_y": 103.4}], "reconstructed": true, "latest_close": 87.73, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug", "live_score_version": "evidence-v9", "comparable_to_live": true}, "sentiment_history": [{"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "25 Jun 23:59", "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": 5, "score_change_display": "+5", "confidence_change": 5, "article_change": 1, "tone": "neutral", "height": 10, "articles": 2, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "26 Jun 23:59", "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 4, "score_change_display": "+4", "confidence_change": 6, "article_change": 1, "tone": "positive", "height": 18, "articles": 3, "confidence": 37, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "01 Jul 23:59", "short_label": "01 Jul", "collected_at": "2026-07-01T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -3, "score_change_display": "-3", "confidence_change": -7, "article_change": 1, "tone": "neutral", "height": 12, "articles": 4, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "06 Jul 23:59", "short_label": "06 Jul", "collected_at": "2026-07-06T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": -2, "score_change_display": "-2", "confidence_change": -5, "article_change": 1, "tone": "neutral", "height": 8, "articles": 5, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "21 Jul 23:59", "short_label": "21 Jul", "collected_at": "2026-07-21T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -3, "score_change_display": "-3", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "23 Jul 23:59", "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 6, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "24 Jul 23:59", "short_label": "24 Jul", "collected_at": "2026-07-24T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "27 Jul 23:59", "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": 3, "article_change": -1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 7, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 6, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "09 Aug 23:59", "short_label": "09 Aug", "collected_at": "2026-08-09T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 8, "articles": 9, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 63, "delta": 13, "score_change": 9, "score_change_display": "+9", "confidence_change": 14, "article_change": 7, "tone": "positive", "height": 26, "articles": 16, "confidence": 47, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 66, "delta": 16, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 3, "tone": "positive", "height": 32, "articles": 19, "confidence": 50, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true}, {"label": "12 Aug 23:59", "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score": 67, "delta": 17, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 5, "tone": "positive", "height": 34, "articles": 24, "confidence": 52, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 66, "delta": 16, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "positive", "height": 32, "articles": 25, "confidence": 49, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v9", "live_version": "evidence-v9", "comparable_to_live": true, "reconstructed": true, "observations": 17, "span_label": "52 days", "first_score": 50, "latest_score": 66, "net_change": 16, "net_change_display": "+16", "direction": "Strengthening", "high_score": 67, "low_score": 50, "latest_confidence": 49, "confidence_change": 23, "latest_articles": 25, "article_change": 24, "latest_label": "13 Aug 23:59", "latest_evidence_label": "Measured", "chart_rows": [{"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 42.0, "y": 135.0}, {"label": "25 Jun 23:59", "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": 5, "score_change_display": "+5", "confidence_change": 5, "article_change": 1, "tone": "neutral", "height": 10, "articles": 2, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 99.2, "y": 125.9}, {"label": "26 Jun 23:59", "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": 4, "score_change_display": "+4", "confidence_change": 6, "article_change": 1, "tone": "positive", "height": 18, "articles": 3, "confidence": 37, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 156.5, "y": 118.6}, {"label": "01 Jul 23:59", "short_label": "01 Jul", "collected_at": "2026-07-01T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -3, "score_change_display": "-3", "confidence_change": -7, "article_change": 1, "tone": "neutral", "height": 12, "articles": 4, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 213.8, "y": 124.1}, {"label": "06 Jul 23:59", "short_label": "06 Jul", "collected_at": "2026-07-06T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": -2, "score_change_display": "-2", "confidence_change": -5, "article_change": 1, "tone": "neutral", "height": 8, "articles": 5, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 271.0, "y": 127.7}, {"label": "21 Jul 23:59", "short_label": "21 Jul", "collected_at": "2026-07-21T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -3, "score_change_display": "-3", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 328.2, "y": 133.2}, {"label": "23 Jul 23:59", "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 6, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 385.5, "y": 133.2}, {"label": "24 Jul 23:59", "short_label": "24 Jul", "collected_at": "2026-07-24T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 442.8, "y": 133.2}, {"label": "27 Jul 23:59", "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": 3, "article_change": -1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 500.0, "y": 135.0}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 557.2, "y": 135.0}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 7, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 614.5, "y": 135.0}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 6, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 671.8, "y": 131.4}, {"label": "09 Aug 23:59", "short_label": "09 Aug", "collected_at": "2026-08-09T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 8, "articles": 9, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true, "x": 729.0, "y": 127.7}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 63, "delta": 13, "score_change": 9, "score_change_display": "+9", "confidence_change": 14, "article_change": 7, "tone": "positive", "height": 26, "articles": 16, "confidence": 47, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true, "x": 786.2, "y": 111.3}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 66, "delta": 16, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 3, "tone": "positive", "height": 32, "articles": 19, "confidence": 50, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true, "x": 843.5, "y": 105.9}, {"label": "12 Aug 23:59", "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score": 67, "delta": 17, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 5, "tone": "positive", "height": 34, "articles": 24, "confidence": 52, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true, "x": 900.8, "y": 104.1}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 66, "delta": 16, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "positive", "height": 32, "articles": 25, "confidence": 49, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true, "x": 958.0, "y": 105.9}], "chart_points": "42.0,135.0 99.2,125.9 156.5,118.6 213.8,124.1 271.0,127.7 328.2,133.2 385.5,133.2 442.8,133.2 500.0,135.0 557.2,135.0 614.5,135.0 671.8,131.4 729.0,127.7 786.2,111.3 843.5,105.9 900.8,104.1 958.0,105.9", "changes": [{"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 66, "delta": 16, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "positive", "height": 32, "articles": 25, "confidence": 49, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true}, {"label": "12 Aug 23:59", "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score": 67, "delta": 17, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 5, "tone": "positive", "height": 34, "articles": 24, "confidence": 52, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 66, "delta": 16, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 3, "tone": "positive", "height": 32, "articles": 19, "confidence": 50, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 63, "delta": 13, "score_change": 9, "score_change_display": "+9", "confidence_change": 14, "article_change": 7, "tone": "positive", "height": 26, "articles": 16, "confidence": 47, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v9", "reconstructed": true}, {"label": "09 Aug 23:59", "short_label": "09 Aug", "collected_at": "2026-08-09T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 8, "articles": 9, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 6, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 0, "tone": "neutral", "height": 4, "articles": 7, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v9", "reconstructed": true}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}